Jabeen, S <br/><br/>
Impact of genetic variants of RFC1, DHFR and MTHFR in osteosarcoma patients treated with high-dose methotrexate.  [electronic resource] 

 -  The pharmacogenomics journal  Oct 2015 
 - 385-90 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1473-1150 
<br/><br/><label>Standard No.: </label>10.1038/tpj.2015.11  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alleles<br/>Disease-Free Survival<br/>Dose-Response Relationship, Drug<br/>Female<br/>Humans<br/>Kaplan-Meier Estimate<br/>Male<br/>Methotrexate--administration & dosage<br/>Methylenetetrahydrofolate Reductase (NADPH2)--genetics<br/>Osteosarcoma--drug therapy<br/>Polymorphism, Single Nucleotide<br/>Replication Protein C--genetics<br/>Tetrahydrofolate Dehydrogenase--genetics